DEF: James River Group Refocuses, Reports Mixed 2024 Results

Sentiment:

Proxy Statement


James River Group Holdings, Ltd. details its 2024 strategic transformation, mixed financial performance, and upcoming shareholder proposals, including executive compensation and equity plan amendments.

Capital raiseOn February 24, 2022, the company issued and sold 150,000 Series A Perpetual Cumulative Convertible Preferred Shares for an aggregate purchase price of $150 million to GPC Thames, an affiliate of Gallatin Point Capital LLC.On November 11, 2024, Gallatin Point exchanged 37,500 Series A Preferred Shares for 5,859,375 common shares, equivalent to a price of $6.40 per share.On November 11, 2024, the company entered into a Subscription Agreement with Cavello Bay Reinsurance Limited, providing for the issuance and sale of 1,953,125 common shares for an aggregate purchase price of $12.5 million, or $6.40 per share. This share sale closed on December 23, 2024.
Worse than expectedThe company reported a net loss of $(81,120) thousand for the fiscal year ended December 31, 2024.Total Shareholder Return (TSR) of $13.16 significantly underperformed the Peer Group TSR of $227.67.Executive short-term incentive payouts for group leaders (77.1% of target) and the Excess & Surplus Lines segment leader (59.1% of target) were below their respective targets, even after adjustments for strategic activities, indicating that underlying financial performance for these metrics did not meet expectations.

Summary

  • The company completed a strategic review in 2024, leading to a renewed focus on its U.S. Excess & Surplus Lines (E&S) business.
  • Key strategic actions included the sale of JRG Reinsurance Company Ltd., two retroactive reinsurance transactions totaling $160.0 million (E&S ADC) and an additional $75.0 million (E&S Top Up ADC) for the E&S business, and the conversion of $37.5 million of Series A Preferred Shares to common shares.
  • Gross written premium for the E&S segment exceeded $1.0 billion for the second consecutive year, with a slight increase from the prior year and a positive renewal rate change of 9.0%.
  • Net investment income increased by 10.8% in 2024 compared to 2023.
  • The Specialty Admitted Insurance segment reported a combined ratio of 92.2% for 2024, an improvement from 95.9% in 2023, and underwriting profit grew by 68.6%.
  • Despite strategic progress, the company reported a net loss of $(81,120) thousand for 2024.
  • Executive short-term incentive payouts for 2024 were adjusted due to strategic activities, resulting in payouts below target for group leaders (77.1%) and the E&S segment leader (59.1%), but above target for the Specialty Admitted segment leader (93.1%).
  • Shareholders will vote on the election of eight directors, the re-appointment of Ernst & Young LLP as auditor, the advisory approval of 2024 executive compensation, and amendments to two equity incentive plans at the Annual General Meeting on October 23, 2025.

Sentiment

Score: 4

Explanation: The company is undergoing significant strategic restructuring and de-risking, which are positive long-term steps. However, the reported net loss for 2024 and substantial underperformance in Total Shareholder Return compared to peers indicate significant challenges and a negative short-to-medium term outlook. While some segments show improvement, overall financial results are weak, and executive compensation adjustments highlight underlying issues.

Positives

  • Completed a strategic review in 2024, leading to a renewed focus on profitable scale in the U.S. Excess & Surplus Lines (E&S) business.
  • De-risked the organization through two retroactive reinsurance transactions: a $160.0 million combined loss portfolio transfer and adverse development cover (E&S ADC) and an additional $75.0 million adverse development cover (E&S Top Up ADC) for the E&S business.
  • Received validating equity investments from two sophisticated investors (Enstar Group Limited and Gallatin Point Capital LLC).
  • Streamlined operations by closing the sale of JRG Reinsurance Company Ltd.
  • Excess & Surplus Lines segment gross written premium exceeded $1.0 billion for a second consecutive year, showing a slight increase from the prior year.
  • Achieved highest levels of both new and renewal annual submission growth in five years, with a positive renewal rate change of 9.0% for 2024.
  • Full year 2024 net investment income increased 10.8% compared to 2023.
  • Specialty Admitted Insurance segment combined ratio improved to 92.2% for 2024 from 95.9% for 2023.
  • Underwriting profit for the Specialty Admitted Insurance segment grew 68.6% compared to the prior year.
  • Strategic goals for executive compensation, focused on technology improvements and underwriting performance tools, were achieved at 100% of target.

Negatives

  • Reported a net loss of $(81,120) thousand for the fiscal year ended December 31, 2024.
  • Total Shareholder Return (TSR) of $13.16 significantly underperformed the Peer Group TSR of $227.67 for the period starting December 31, 2019, through December 31, 2024.
  • Group adjusted combined ratio for executive compensation purposes was 99.5%, below target but above minimum payout.
  • Excess & Surplus Lines segment adjusted combined ratio for executive compensation purposes was 94.9%, below the minimum payout.
  • Group Adjusted EBIT for executive compensation purposes was $104.8 million, below target but above minimum payout.
  • Executive short-term incentive payouts for group leaders (77.1% of target) and the E&S segment leader (59.1% of target) were below their respective targets, even after adjustments for strategic activities.

Risks

  • Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected.
  • The company's ability to attract, retain, and incentivize talented employees is critical, and failure to approve equity plan amendments could put the company at a competitive disadvantage.
  • Cybersecurity risks are a significant concern, requiring substantial efforts in managing systems and data protection.
  • The company's compensation policies and practices are monitored to ensure they do not encourage excessive or unnecessary risk-taking.
  • Potential adverse tax consequences under Section 409A of the Code related to deferred compensation and equity awards.
  • The company is subject to various legal and regulatory requirements, including SEC rules and Nasdaq listing standards, which could impact operations and financial reporting.

Future Outlook

The company intends to change its jurisdiction of incorporation from Bermuda to Delaware, effective around November 7, 2025, a process referred to as the Domestication. The strategic review completed in 2024 has led to a renewed focus on adding profitable scale to the Excess & Surplus Lines business. The company continues to invest in technology improvements and underwriting performance tracking tools. Future executive compensation will continue to be tied to multi-year strategic goals and long-term shareholder value creation, with performance-based equity awards vesting over three years.

Management Comments

  • Frank N. DOrazio, CEO: 'We look forward to seeing you at the Annual Meeting.'
  • The Committee believes that the adjusted items (for STI payouts) were outside the control of management and were not representative of operating performance, and that the adjustments were necessary to preserve the motivational objective of the STI Plan.
  • The Committee recognized the significant involvement of Messrs. DOrazio and Hoffmann and Ms. Doran in the negotiation and execution of the E&S ADC and the E&S Top Up ADC.
  • The Committee recognized Mr. DOrazio and Ms. Doran in the closing of the sale of JRG Reinsurance Company Ltd., the equity investment in the Company by Enstar Group Limited and the amendment and conversion of Series A Preferred Shares by Gallatin Point.
  • The Committee recognized Ms. Doran in the 10.8% increase in the Company's investment portfolio return.
  • The Committee recognized Mr. Bowman in the outperformance of the Specialty Admitted Insurance segment's combined ratio compared to the STI Plan metrics.
  • The Committee acknowledged Mr. Schmitzer's contribution to the production of $1 billion in gross written premium by the Excess & Surplus Lines segment for the second consecutive year.

Industry Context

The company operates in the specialty insurance sector, which often involves niche property, casualty, and surety markets. The strategic shift to focus on U.S. Excess & Surplus Lines (E&S) aligns with a segment known for its flexibility and ability to underwrite unique or higher-risk exposures, potentially offering higher margins. The use of retroactive reinsurance transactions is a common industry practice for de-risking legacy liabilities and strengthening balance sheets. The equity investments from sophisticated sector investors like Enstar Group Limited and Gallatin Point Capital LLC suggest a validation of the company's strategic direction and potential for future growth within its refocused segments. The underperformance in Total Shareholder Return compared to the S&P 500 Property & Casualty Insurance Index indicates that while internal strategic actions are underway, the company has lagged broader industry performance, possibly due to past challenges or the ongoing transition.

Comparison to Industry Standards

  • The company's Total Shareholder Return (TSR) of $13.16 (based on a $100 initial investment from Dec 31, 2019, to Dec 31, 2024) significantly underperformed the S&P 500 Property & Casualty Insurance Index TSR of $227.67 over the same period, indicating substantial underperformance relative to industry benchmarks.
  • The Specialty Admitted Insurance segment's combined ratio of 92.2% for 2024 is generally considered strong within the property and casualty insurance industry, as a ratio below 100% indicates underwriting profitability. This compares favorably to its 95.9% in 2023.
  • The Excess & Surplus Lines segment's adjusted combined ratio of 94.9% for executive compensation purposes, while below the internal minimum payout target, still represents an underwriting profit, which is a positive indicator in the E&S market.
  • The 9.0% positive renewal rate change in the E&S segment suggests the company is maintaining pricing discipline and potentially benefiting from favorable market conditions, which is a key trend in the specialty insurance market.
  • The 10.8% increase in net investment income is a positive sign, especially in a fluctuating interest rate environment, and compares to broader industry efforts to optimize investment portfolios.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President, Excess and Surplus Lines segmentRichard J. SchmitzerTodd R. Sutherland2025-05-05Richard J. Schmitzer stepped down in anticipation of retirement; Todd R. Sutherland appointed.
Chief Executive Officer, Excess and Surplus Lines segmentRichard J. SchmitzerTodd R. Sutherland (implied, as he became President)2025-07-31Richard J. Schmitzer stepped down in anticipation of retirement.
President and Chief Executive Officer, Specialty Admitted Insurance segmentWilliam K. BowmanN/A (Stepped down, retirement pending)2025-09-01William K. Bowman stepped down in anticipation of retirement.
Non-Executive Chairperson of the BoardOllie L. Sherman, Jr.Christine LaSala2025-02Ollie L. Sherman, Jr. retired from the Board in April 2025; Christine LaSala appointed.
DirectorN/AJoel D. Cavaness2025-07New appointment to the Board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionEight directors nominated for election, including new director Joel D. Cavaness and Non-Executive Chairperson Christine LaSala.2025-10-23Aims to enhance board expertise in insurance, finance, and risk management, with a focus on independence (7 out of 8 nominees are independent).
Equity Incentive Plan AmendmentProposal to increase authorized common shares for issuance under the 2014 Long-Term Incentive Plan by 1,650,000 shares to a total of 7,157,650 shares.Upon shareholder approval at 2025 AGMCritical for attracting, retaining, and incentivizing talented employees by providing competitive equity incentives, aligning interests with shareholders, but also increases potential dilution.
Non-Employee Director Incentive Plan AmendmentProposal to increase authorized common shares for issuance under the 2014 Non-Employee Director Incentive Plan by 225,000 shares to a total of 475,000 shares.Upon shareholder approval at 2025 AGMAims to attract and retain qualified non-employee directors by offering competitive equity compensation, fostering proprietary interest in company success, with minimal dilution impact (0.2% of shares outstanding).
Clawback PolicyExecutive officer incentive compensation recovery policy adopted in October 2023, in compliance with Dodd-Frank Act and SEC/Nasdaq rules.2023-10Strengthens accountability by requiring executive officers to return incentive compensation if financial statements are restated due to material noncompliance or error, aligning with best governance practices.
Share Ownership GuidelinesGuidelines adopted in July 2022 requiring CEO to own 5x base salary, other executive officers 3x base salary, and non-employee directors 3x annual cash retainer in common shares within five years.2022-07Enhances alignment of financial interests between management/directors and shareholders, promoting a long-term perspective.
Insider Trading PolicyPolicy prohibits pledging, hedging, short sales, margin accounts, and trading in exchange-traded options or other derivative securities by directors, officers, and employees.N/A (existing policy)Mitigates risks associated with insider trading and promotes ethical conduct and compliance with securities laws.
DomesticationIntention to change jurisdiction of incorporation from Bermuda to Delaware.Expected around 2025-11-07Simplifies corporate structure and potentially aligns with U.S. regulatory and legal frameworks, which may be viewed favorably by U.S. investors.

Related Party Transactions

  • Investment Agreement with GPC Thames (an affiliate of Gallatin Point Capital LLC, where director Matthew B. Botein is a Managing Partner) for the issuance and sale of 150,000 Series A Preferred Shares for $150 million on February 24, 2022.
  • GPC Thames is entitled to designate one individual for nomination to the Board of Directors (Mr. Botein) as long as certain ownership thresholds are met.
  • Amendment to the Investment Agreement on November 11, 2024, where Gallatin Point exchanged 37,500 Series A Preferred Shares for 5,859,375 common shares at $6.40 per share, and modified conversion provisions.
  • Subscription Agreement with Cavello Bay Reinsurance Limited (an affiliate of Enstar Group Limited) on November 11, 2024, for the issuance and sale of 1,953,125 common shares for $12.5 million ($6.40 per share), which closed on December 23, 2024.
  • Simultaneously, Cavello Bay entered into the E&S Top Up ADC with James River subsidiaries, reinsuring 100% of E&S segment losses (2010-2023) for a premium of $52.8 million, subject to a $1,183.7 million retention and $75.0 million aggregate limit, closed on December 23, 2024.
  • On April 11, 2025, an agreement with entities controlled by Sixth Street (an affiliate of Cavello Bay) for the E&S segment to invest up to $75 million into a private asset-based credit strategy, with an annual management fee of 1% of the invested amount and potential performance fees.

Stakeholder Impact

  • **Shareholders**: Potential dilution from proposed equity plan amendments (1,650,000 additional shares for employees, 225,000 for non-employee directors). The conversion of Series A Preferred Shares to common shares and new common share issuance to Cavello Bay also impact ownership structure. The net loss and underperforming TSR are negative, while strategic de-risking and refocusing aim for long-term value.
  • **Employees**: Executive compensation program aims to attract and retain talent through base salaries, short-term incentives, and long-term equity awards. Cash retention awards were provided to key NEOs during the strategic review. The proposed increase in shares for the Long-Term Incentive Plan is intended to ensure competitive compensation and retention.
  • **Customers**: The renewed focus on the U.S. Excess & Surplus Lines business and ongoing technology improvements are intended to improve efficiency and customer experience.
  • **Management**: Executive compensation is tied to financial and strategic goals, with adjustments made for strategic activities. Management changes, including retirements and new appointments, indicate a transition in leadership. The domestication to Delaware may impact legal and regulatory oversight.
  • **Regulatory Bodies**: The domestication to Delaware will shift regulatory oversight from Bermuda to U.S. frameworks. Compliance with SEC rules, Nasdaq listing standards, and other governmental laws is emphasized in corporate governance policies.

Next Steps

  • Hold the Annual General Meeting of Shareholders on October 23, 2025, to vote on director elections, auditor re-appointment, executive compensation, and equity plan amendments.
  • Complete the Domestication process, changing the jurisdiction of incorporation from Bermuda to Delaware, expected around November 7, 2025.
  • Continue to implement the renewed focus on adding profitable scale to the U.S. Excess & Surplus Lines business.
  • Continue to develop and implement technology improvements and underwriting performance tracking tools.
  • Richard J. Schmitzer will facilitate a smooth transition of his duties until his retirement on October 15, 2025.
  • William K. Bowman will facilitate a smooth transition of his duties until his retirement on September 30, 2025.
  • The Excess and Surplus Lines segment will invest up to $75 million into a private asset-based credit strategy with Sixth Street, an affiliate of Cavello Bay, starting April 11, 2025.

Key Dates

DateDescription
2014-11-182014 Long-Term Incentive Plan and 2014 Non-Employee Director Incentive Plan initially adopted by the Board and shareholders.
2017-05-02Amendment to 2014 Long-Term Incentive Plan became effective upon shareholder approval, increasing authorized shares by 1,000,000.
2019-04-30Amendment to 2014 Non-Employee Director Incentive Plan became effective upon shareholder approval, increasing authorized shares by 100,000.
2020-11Frank N. DOrazio began serving as PEO (Chief Executive Officer).
2021-01-01Effective date for the start of the performance period for certain long-term incentive awards.
2021-10Thomas L. Brown and Kirstin M. Gould joined the Board of Directors.
2021-11Michael J. Hoffmann began serving as Senior Vice President, Chief Underwriting Officer.
2022-02-24Entered into Investment Agreement with GPC Thames (Gallatin Point affiliate) for issuance of Series A Preferred Shares.
2022-07Board adopted share ownership guidelines for directors and executive officers.
2022-10Peter B. Migliorato joined the Board of Directors.
2022-10-25Second amendment to 2014 Long-Term Incentive Plan became effective upon shareholder approval, increasing authorized shares by 811,500 and extending duration to 2032.
2023-04Dennis J. Langwell joined the Board of Directors.
2023-10Board adopted executive officer incentive compensation recovery (clawback) policy.
2023-11Commencement of strategic review process, anticipated to last 12 months from this date.
2024-02Committee approved grants of awards to NEOs under the 2014 Long-Term Incentive Plan.
2024-03-01Grant date for 2024 equity awards to NEOs.
2024-04Patricia H. Roberts retired from the Board.
2024-07Christine LaSala joined the Board of Directors.
2024-07-02Executed $160.0 million combined loss portfolio transfer and adverse development cover for Excess & Surplus Lines business (E&S ADC).
2024-07-24Compensation and Human Capital Committee and Board approved the 2025 LTIP Amendment and the Non-Employee Director Plan amendment, subject to shareholder approval.
2024-07-25Cash retention awards granted to NEOs (except CEO); Ms. LaSala received a pro-rated restricted share unit award.
2024-10Last annual employee engagement survey conducted with 80% participation rate.
2024-10-24Third amendment to 2014 Long-Term Incentive Plan became effective upon shareholder approval, increasing authorized shares by 525,000. Second amendment to Non-Employee Director Plan became effective upon shareholder approval, increasing authorized shares by 100,000 and extending duration to 2034.
2024-11-11Entered into Investment Agreement Amendment with Gallatin Point, exchanging Series A Preferred Shares for common shares. Entered into Subscription Agreement with Cavello Bay for common shares and E&S Top Up ADC.
2024-12-23Share sale to Cavello Bay closed; E&S Top Up ADC closed.
2024-12-31Fiscal year end for 2024; first installment of cash retention awards vested; number of employees was 642.
2025-02Christine LaSala became Non-Executive Chairperson of the Board.
2025-03-04Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC.
2025-04Ollie L. Sherman, Jr. retired from the Board.
2025-04-11Entered into agreement with Sixth Street (an affiliate of Cavello Bay) for E&S segment to invest up to $75 million into a private asset-based credit strategy.
2025-05-05Richard J. Schmitzer stepped down as President of the Excess and Surplus Lines segment.
2025-05-14Fuller & Thaler Asset Management, Inc. filed Amendment No. 2 to Schedule 13G.
2025-05-20Deadline for shareholder proposals for the 2026 proxy statement (if 2026 AGM is within 30 days of Oct 23, 2026).
2025-06-30Second installment of cash retention awards expected to vest.
2025-07Joel D. Cavaness joined the Board of Directors.
2025-07-24Compensation and Human Capital Committee and Board approved the 2025 LTIP Amendment and the Non-Employee Director Plan amendment, subject to shareholder approval.
2025-07-31Richard J. Schmitzer stepped down as Chief Executive Officer of the Excess and Surplus Lines segment.
2025-08-11Effective date of amendment to Richard J. Schmitzer's employment agreement, changing his title to Senior Vice President, Underwriting.
2025-08-12Richard J. Schmitzer entered into an amendment to his employment agreement.
2025-08-14T. Rowe Price Investment Management, Inc. and Zimmer Partners, LP filed Amendment No. 4 to Schedule 13G and Schedule 13G, respectively.
2025-08-15Company filed registration statement on Form S-3.
2025-08-19Company filed prospectus with the SEC regarding Domestication.
2025-09-01William K. Bowman stepped down as President and Chief Executive Officer of the Specialty Admitted Insurance segment.
2025-09-03Record date for the Annual General Meeting of Shareholders; closing price of common shares was $5.58.
2025-09-17Proxy statement and 2024 Annual Report first mailed to shareholders.
2025-09-30William K. Bowman intends to retire.
2025-10-15Richard J. Schmitzer intends to retire.
2025-10-22Deadline for Internet and telephone voting for the Annual General Meeting (11:59 P.M. Eastern Time).
2025-10-23Annual General Meeting of Shareholders to be held at 8:00 a.m. local time at Rosewood Bermuda.
2025-11-07Expected effective date of the Domestication (change of incorporation jurisdiction from Bermuda to Delaware).
2026-12-31End of performance period for 2024 PRSU awards.
2029-09-30Fixed dividend rate of 7% per annum on Series A Preferred Shares ends; rate resets on October 1, 2029.
2032-07-26Automatic termination date for the 2014 Long-Term Incentive Plan (unless sooner terminated).
2034-10-24Duration of the 2014 Non-Employee Director Incentive Plan extended to this date.

Recommendation

hold

The company is in a transitional phase, marked by significant strategic actions to de-risk and refocus its business on the U.S. Excess & Surplus Lines segment. While these actions, including reinsurance transactions and equity investments, are positive for long-term stability and balance sheet health, the 2024 financial results show a net loss and substantial underperformance in Total Shareholder Return compared to industry peers. The mixed performance in executive compensation metrics, even after adjustments, suggests that the core business is still facing challenges. The proposed equity plan amendments, while necessary for talent retention, will lead to further dilution. Given the ongoing strategic shifts and mixed financial signals, a 'hold' recommendation is appropriate. Investors should monitor the execution of the strategic plan, the impact of the domestication, and future financial performance, particularly the profitability of the refocused E&S segment, before considering a 'buy' or 'sell' position.

Keywords

Insurance, Specialty Insurance, Excess & Surplus Lines, Reinsurance, SEC Filing, Proxy Statement, Corporate Governance, Executive Compensation, Risk Management, Shareholder Meeting, Equity Incentive Plan, Financial Results, Combined Ratio, Net Investment Income, Strategic Review, Domestication

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.